Technical Analysis for HLN - Haleon plc
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | N/A | Up | Flat |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Resistance | Bearish | 0.00% | |
| Stochastic Buy Signal | Bullish | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 1.02% | |
| NR7 | Range Contraction | 1.28% | |
| Oversold Stochastic | Weakness | 1.28% | |
| Stochastic Reached Oversold | Weakness | 1.23% | |
| Oversold Stochastic | Weakness | 1.23% | |
| Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 0.44% | |
| NR7 | Range Contraction | 0.44% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| Rose Above 20 DMA | about 15 hours ago |
| Rose Above 10 DMA | about 16 hours ago |
| Rose Above Previous Day's High | about 19 hours ago |
| Up 1% | about 19 hours ago |
| 20 DMA Resistance | about 19 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Health Glaxosmithkline Consumer Healthcare Products
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Health Glaxosmithkline Consumer Healthcare Products
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 332.35 |
| 52 Week Low | 241.1735 |
| Average Volume | 13,389,358 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 308.75 |
| 20-Day Moving Average | 318.52 |
| 10-Day Moving Average | 318.13 |
| Average True Range | 6.60 |
| RSI | 52.38 |
| ADX | 21.21 |
| +DI | 23.40 |
| -DI | 19.13 |
| Chandelier Exit (Long, 3 ATRs) | 312.56 |
| Chandelier Exit (Short, 3 ATRs) | 330.27 |
| Upper Bollinger Bands | 329.45 |
| Lower Bollinger Band | 307.59 |
| Percent B (%b) | 0.44 |
| BandWidth | 6.86 |
| MACD Line | 1.29 |
| MACD Signal Line | 2.72 |
| MACD Histogram | -1.423 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 323.33 | ||||
| Resistance 3 (R3) | 323.40 | 321.45 | 322.31 | ||
| Resistance 2 (R2) | 321.45 | 319.90 | 321.41 | 321.97 | |
| Resistance 1 (R1) | 319.35 | 318.95 | 320.40 | 319.28 | 321.64 |
| Pivot Point | 317.40 | 317.40 | 317.93 | 317.36 | 317.40 |
| Support 1 (S1) | 315.30 | 315.85 | 316.35 | 315.23 | 312.86 |
| Support 2 (S2) | 313.35 | 314.90 | 313.31 | 312.53 | |
| Support 3 (S3) | 311.25 | 313.35 | 312.19 | ||
| Support 4 (S4) | 311.18 |
